Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on July 14, 2025
Branded Legacy Inc. Announces Leadership Transition and Pending Merger with Innovative Addiction Therapeutics Company Projecting $40 Million in First-Year Revenue
GlobeNewswire
·
July 14, 2025
ORLANDO, Fla., July 14, 2025 (GLOBE NEWSWIRE) -- via IBN -- Branded Legacy Inc. (OTC: BLEG), a diversified holdings company, today announced significant changes in its leadership structure and a strategic merger initiative aimed at positioning the company …
2024 Robotics Technology Market Research Review: Presentation of Pioneering Advances in Robotics
GlobeNewswire
·
July 14, 2025
Boston, July 14, 2025 (GLOBE NEWSWIRE) -- BCC Research announces the release of its “2024 Robotics Technology Research Review,” putting a spotlight on the significant growth and advances in the global markets for robotics, drone technology, and pharmacy …
Muscle Endurance: Bodybuilders Turn to CrazyBulk Natural Legal Steroids and BodyBuilding Supplements For Muscle Growth
GlobeNewswire
·
July 14, 2025
New York City, NY, July 14, 2025 (GLOBE NEWSWIRE) -- As the fitness world continues to evolve, a growing number of athletes and everyday lifters are shifting focus from sheer size to functional strength and muscular endurance. In 2025, this movement is …
Waldenstrom Macroglobulinemia Market Sees Surging Demand Across the 7MM Amid BTK Inhibitor Advancements | DelveInsight
GlobeNewswire
·
July 14, 2025
New York, USA, July 14, 2025 (GLOBE NEWSWIRE) -- Waldenstrom Macroglobulinemia Market Sees Surging Demand Across the 7MM Amid BTK Inhibitor Advancements | DelveInsight The Waldenstrom macroglobulinemia market is witnessing steady growth driven by advances …
Strength Training For Women: CrazyBulk Legal Steroid Alternatives Are Changing the Muscle Building Supplements Game
GlobeNewswire
·
July 14, 2025
New York City, NY, July 14, 2025 (GLOBE NEWSWIRE) -- Introduction: Why Strength Training for Women Is Evolving in 2025 In 2025, strength training is no longer confined to male-dominated gym floors. Across the globe, more women are stepping into power racks …
Survey: Public Health Workers Are Younger, Committed, and Burned Out
GlobeNewswire
·
July 14, 2025
Bethesda, Md., July 14, 2025 (GLOBE NEWSWIRE) -- Findings from the 2024 Public Health Workforce Interests and Needs Survey (PH WINS) provide a unique snapshot of the government public health workforce, including the evolving demographics, job …
The Foundation for Sarcoidosis Research Awards $450,000 to Support Early-Career Investigators Through the 2025 Fellowship Grant
GlobeNewswire
·
July 14, 2025
CHICAGO, July 14, 2025 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) is proud to announce the three recipients of the 2025 FSR Early Career Fellowship Grant: William Lippitt, PhD, (University of Colorado Anschutz Medical Campus), Juan …
Ascentage Pharma Announces Pricing of Top-Up Placement
GlobeNewswire
·
July 14, 2025
ROCKVILLE, Md. and SUZHOU, China, July 14, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International Inc. (NASDAQ: AAPG; HKEX: 6855) (“Ascentage” or the “Company”), a global biopharmaceutical company dedicated to addressing unmet medical needs in …
TTAM Research Institute, A Nonprofit Public Benefit Corporation, Completes The Acquisition of 23andMe Assets
GlobeNewswire
·
July 14, 2025
SAN FRANCISCO, July 14, 2025 (GLOBE NEWSWIRE) -- TTAM Research Institute (“TTAM”), a nonprofit public benefit corporation based in California and founded and led by Anne Wojcicki, today announced that it has completed the acquisition of the Personal Genome …
Tevogen.AI Builds Alpha Version of PredicTcell™ Model with Microsoft and Databricks; Observes Drastic Time Reduction in Target Analysis Translating to Potential Savings of Billions in Drug Development Costs
GlobeNewswire
·
July 14, 2025
Tevogen.AI’s model drastically reduces target analysis and has the potential to generate billions in cost savings across the healthcare system by streamlining early-stage drug discovery, reducing wet lab dependency, and accelerating timelines. Beyond cost …
BiomX Announces Successful Initiation of Phase 2b Trial with First Patient Dosed in BX004 Program in Patients with Cystic Fibrosis
GlobeNewswire
·
July 14, 2025
First patient dosing in Company’s Phase 2b trial marks pivotal milestone in phage therapy development program targeting antibiotic-resistant lung infections in Cystic Fibrosis patients; topline results are expected in Q1 2026 Prior Phase 1b/2a efficacy …
Borvo EVAC™ System Demonstrates 100% Success Rate in Chronic Subdural Hematoma Clinical Cases Validated Across 5 Medical Centers
GlobeNewswire
·
July 14, 2025
MOUNTAIN VIEW, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- Borvo Medical, a neurosurgical medtech startup and a portfolio company of NeuroTechnology Investors (NTI), today announced a 100% success rate across five medical centers using the FDA-cleared Borvo …
Pineapple, Inc. to Launch Real-World Asset Token Designed to Monetize Intellectual Property
GlobeNewswire
·
July 14, 2025
Tokenized IP platform built to enable access, utility, and engagement with Pineapple branded proprietary assets LOS ANGELES, CA, July 14, 2025 (GLOBE NEWSWIRE) -- Pineapple, Inc. (OTC: PNPL) (“Pineapple” or the “Company”) today announced its strategic …
NEXGEL and STADA AG Announce Expansion of Partnership for North America
GlobeNewswire
·
July 14, 2025
LANGHORNE, Pa., July 14, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced expanding its …
Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi™
GlobeNewswire
·
July 14, 2025
Payer coverage for Emrosi™ now available for 65% of commercial lives, up from 29% in May 2025 Expanding payer coverage supports the adoption of Emrosi as prescription demand continues to increase SCOTTSDALE, Ariz., July 14, 2025 (GLOBE NEWSWIRE) -- Journey …
Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)
GlobeNewswire
·
July 14, 2025
July 14, 2025 Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP) Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a …
Derma Fillers Market worth $7.32 billion by 2030 with 12.1% CAGR | MarketsandMarkets™.
GlobeNewswire
·
July 14, 2025
Delray Beach, FL, July 14, 2025 (GLOBE NEWSWIRE) -- The global derma fillers market, valued at US$3.74 billion in 2024 stood at US$4.13 billion in 2025 and is projected to advance at a resilient CAGR of 12.1% from 2025 to 2030, culminating in a forecasted …
Ciao Bella! Euro Summer Starts Right Here in Canada at Chopped Leaf
GlobeNewswire
·
July 14, 2025
Oakville, Ontario, Canada, July 14, 2025 (GLOBE NEWSWIRE) -- OAKVILLE, ON – Fresh, light and full of flavour, Chopped Leaf is introducing two new low-calorie, summer-fresh salads: the Antipasto Salad and Peach Caprese Salad, available across Canada …
Disc Medicine Appoints Nadim Ahmed to its Board of Directors
GlobeNewswire
·
July 14, 2025
WATERTOWN, Mass., July 14, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious …
Salarius Pharmaceuticals Granted Additional Extension to Regain Compliance with Nasdaq’s Stockholders’ Equity Standard
GlobeNewswire
·
July 14, 2025
HOUSTON, July 14, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) (Salarius or the Company) announces that on July 10, 2025 the Company received notification from The Nasdaq Stock Market LLC (Nasdaq) of an additional extension to …